Literature DB >> 12621678

Intestinal nematodes and pulmonary tuberculosis.

Ricardo Tristão-Sá1, Rodrigo Ribeiro-Rodrigues, Luciléia T Johnson, Fausto Edmundo L Pereira, Reynaldo Dietze.   

Abstract

We report a significantly higher prevalence of intestinal nematodes in patients with pulmonary tuberculosis (TB) compared to a matched control group: 33/57 (57.8%) in patients with TB and 18/86 (20.9%) in the control group; OR = 5.19; 95% CI = 2.33-11.69; p = 0.000). When TB patients eosinophilia was also significantly higher among those with intestinal parasites (69.8%) compared to those without this condition (45.6%). We hypothesized that the immune modulation induced by nematodes is a factor that enhances TB infection/progression and that eosinophilia seen in TB patients is a consequence of helminth infection.

Entities:  

Mesh:

Year:  2002        PMID: 12621678     DOI: 10.1590/s0037-86822002000500020

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  32 in total

1.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Paradoxical helminthiasis and giardiasis in Cape Town, South Africa: epidemiology and control.

Authors:  Vera J Adams; Miles B Markus; Joanita F A Adams; Esme Jordaan; Bronwyn Curtis; Muhammad A Dhansay; Charlie C Obihara; John E Fincham
Journal:  Afr Health Sci       Date:  2005-06       Impact factor: 0.927

Review 3.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

4.  Paradoxical helminthiasis and giardiasis in Cape Town, South Africa: epidemiology and control.

Authors:  Vera J Adams; Miles B Markus; Joanita F A Adams; Esme Jordaan; Bronwyn Curtis; Muhammad A Dhansay; Charlie C Obihara; John E Fincham
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

5.  Strongyloides stercoralis Coinfection Is Associated With Greater Disease Severity, Higher Bacterial Burden, and Elevated Plasma Matrix Metalloproteinases in Pulmonary Tuberculosis.

Authors:  Nathella P Kumar; Gokul R Kathamuthu; Kadar Moideen; Vaithilingam V Banurekha; Dina Nair; Michael P Fay; Thomas B Nutman; Subash Babu
Journal:  J Infect Dis       Date:  2020-08-17       Impact factor: 5.226

6.  Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Emily M Mace; Kimal Rajapakshe; Godwin Mtetwa; Alexander Kay; Gugu Maphalala; W Evan Secor; Rojelio Mejia; Jordan S Orange; Cristian Coarfa; Kapil N Bhalla; Edward A Graviss; Anna M Mandalakas; George Makedonas
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

Review 7.  Helminth-Tuberculosis Co-infection: An Immunologic Perspective.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Trends Immunol       Date:  2016-08-05       Impact factor: 16.687

Review 8.  Helminth infection in populations undergoing epidemiological transition: a friend or foe?

Authors:  Aprilianto Eddy Wiria; Yenny Djuardi; Taniawati Supali; Erliyani Sartono; Maria Yazdanbakhsh
Journal:  Semin Immunopathol       Date:  2012-11-06       Impact factor: 9.623

Review 9.  Effect of helminth-induced immunity on infections with microbial pathogens.

Authors:  Padmini Salgame; George S Yap; William C Gause
Journal:  Nat Immunol       Date:  2013-11       Impact factor: 25.606

10.  Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis.

Authors:  Lindsey E Bazzone; Patrick M Smith; Laura I Rutitzky; Mara G Shainheit; Joseph F Urban; Tommy Setiawan; Arthur M Blum; Joel V Weinstock; Miguel J Stadecker
Journal:  Infect Immun       Date:  2008-08-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.